Global Analgesics Infusion Pump Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Patient-Controlled Analgesia (PCA Pump), Electronic Ambulatory Pumps, and Disposable Infusion Pumps), By Application (Post-Operative Pain Management, Cancer Pain Management, Labor Pain Management, and Chronic Pain Management), By End User (Home Care Settings, Hospitals, and Ambulatory Surgical Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

According to Spherical Insights, the Global Analgesics Infusion Pump Market Size is expected to grow from USD 16.3 Billion in 2024 to USD 36.4 Billion by 2035, at a CAGR of 7.58% during the forecast period 2025-2035.    

Global Analgesics Infusion Pump Market Insights Forecasts to 2035

1. The Global Analgesics Infusion Pump Market Size Was Estimated at USD 16.3 Billion in 2024
2. The Market Size is Expected to Grow at a CAGR of around 7.58% from 2025 to 2035
3. The Worldwide Analgesics Infusion Pump Market Size is Expected to Reach USD 36.4 Billion by 2035

Key Takeaways -

1. North America dominated the market with the largest share in 2024.  
2. Asia Pacific is expected to grow the fastest during the forecast period.
3. By product type, the PCA pump segment dominates the analgesics infusion pump market, while the electronic ambulatory pumps segment is the emerging segment in the market.
4. By application, the postoperative pain management segment is anticipated to hold the dominant share; on the other hand, the cancer pain management segment is growing at the fastest CAGR during the forecast period.
5. By end user, the hospitals segment dominates the analgesics infusion pump market, on the other hand, the home care settings segment is projected to grow rapidly during the forecast period.  

According to a research report published by Spherical Insights and Consulting, the Global Analgesics Infusion Pump Market size was worth around USD 16.3 Billion in 2024 and is predicted to grow to around USD 36.4 Billion by 2035 with a compound annual growth rate (CAGR) of 7.58% from 2025 and 2035. The market for analgesics infusion pump has a number of opportunities to grow due to the growing emphasis on developing smart, connected pumps in the emerging economies. Further, portable, wearable, and disposable devices are used for ambulatory care in the analgesics infusion pump market.

Market Overview

The global analgesics infusion pump industry is the market for medical devices, including patient-controlled analgesia (PCA) pumps, syringe pumps, and ambulatory pumps that deliver medication (like opioids) directly into the body. Analgesics infusion pumps, often known as patient-controlled analgesia pumps, are a computerized device that enables patients to self-administer controlled doses of pain medication (usually opioids) by pressing a button. It is used when patients are unable to self-administer, for treating acute, chronic, postoperative, and labor pain. Various medications can be used for patient-controlled analgesia, which is administered intravenously through an epidural or peripheral nerve catheter, or transdermally.

Innovation and market expansion are anticipated as a result of major players' growing R&D expenditures for developing technologically advanced devices. For instance, in January 2024, KIMM developed technology for detecting the injection of medication to prevent medical accidents related to analgesic drug infusion pumps in hospitals. To prevent the occurrence of these accidents, a drug infusion pump featuring a technology for safely detecting medication administration has been developed for the first time in the world.    

Report Coverage

This research report categorizes the analgesics infusion pump market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the analgesics infusion pump market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the analgesics infusion pump market.  

Driving Factors

Growing prevalence of chronic diseases and an increasing geriatric population

The pumps have better pain control and satisfaction compared to nurse-administered boluses. They experience less anxiety and can relax as they feel more in control of their pain and pain medication. Further, pain is very common in older people, and it is estimated that 40-75% of people living at home and up to 90% in care facilities suffer from chronic pain. The use of an analgesic infusion pump for chronic pain management is driving the market demand, as the prevalence of chronic diseases and the geriatric population is growing.  

Need for effective post-operative pain management

Use of a continuous infusion system providing local anesthetic post-operatively without injected or oral narcotics may be the best pain relief option available for these patients. The system markedly reduced the need for supplemental pain medication following colon resection.

Restraining Factors

Increased initial investment, stringent regulation, risk of complication

Analgesics infusion pump’s regulatory complexity due to their nature as safety-critical devices blending mechanical, electrical, and software components is challenging the market. Further, the high initial investment and incidence of device-related errors that are responsible for adverse clinical outcomes may hamper the market demand.  

Market Segmentation

The Analgesics Infusion Pump Market share is classified into product type, application, and end user.

1. The patient-controlled analgesia pump (PCA pumps) segment dominated the analgesics infusion pump market in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the product type, the analgesics infusion pump market is divided into patient-controlled analgesia pump (PCA pumps), electronic ambulatory pumps, and disposable infusion pumps. Among these, the patient-controlled analgesia pump (PCA pumps) segment dominated the analgesics infusion pump market in 2024 and is projected to grow at a substantial CAGR during the forecast period. This is due to the inclination towards precision pain control and smart pumps that cut infusion-related drug errors. While the electronic ambulatory pumps segment is emerging in the analgesics infusion pump market, as they provide controlled intravenous therapy safely and efficiently.   

2. The post-operative pain management segment accounted for the largest share of over 50.0% in 2024 and is projected to grow at a significant CAGR during the forecast period.

Based on the application, the analgesics infusion pump market is divided into post-operative pain management, cancer pain management, labor pain management, and chronic pain management. Among these, the post-operative pain management segment accounted for the largest share of over 50.0% in 2024 and is projected to grow at a significant CAGR during the forecast period. Analgesic infusion pumps, like patient-controlled analgesia (PCA), are commonly used in post-operative pain management for administering intravenous opioids for moderate to severe pain, enabling patients to self-administer exact dosages. While the cancer pain management segment is the fastest growing segment, in which computerized ambulatory patient-controlled analgesia pump is used for managing chronic cancer pain.  

3. The hospitals segment accounted for the dominant market share of around 52.5% in 2024 and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the analgesics infusion pump market is divided into home care settings, hospitals, and ambulatory surgical centers. Among these, the hospitals segment accounted for the dominant market share of around 52.5% in 2024 and is projected to grow at a substantial CAGR during the forecast period. Analgesics infusion pumps are computerized hospital devices used for safely self-administering pain medication via IV, ensuring consistent pain relief. Further, the home care settings segment is a growing segment due to improved patient management and reduced nursing workload, along with an increasing geriatric population.

Regional Segment Analysis of the Analgesics Infusion Pump Market

1. North America (U.S., Canada, Mexico) 
2. Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
3. Asia-Pacific (China, Japan, India, Rest of APAC)
4. South America (Brazil and the Rest of South America) 
5. The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the analgesics infusion pump market over the predicted timeframe.

North America is anticipated to hold the largest share of about 41.0% in the analgesics infusion pump market over the predicted timeframe. The market ecosystem in North America is strong, due to the increased chronic disease prevalence, number of surgical procedures, and demand for smart, home-based pain management solutions. The U.S. is leading the North America analgesics infusion pump market, capturing about 86.0% region’s share owing to its extensive usage in clinical settings like hospitals, nursing homes, and in the home. 

Asia Pacific is expected to grow at a rapid CAGR of approximately 4.1% in the analgesics infusion pump market during the forecast period. The Asia Pacific area has a thriving market for analgesics infusion pumps due to the enhanced accessibility to sophisticated medical technologies and increased capital investments in healthcare infrastructure, especially in the rural and underserved population. China is the leading country in the region’s market, growing at a CAGR rate of 4.2% during the forecast period, driven by the broader healthcare technology landscape along with an increasing incidence of chronic pain conditions.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the analgesics infusion pump market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

1. Smiths Medical
2. Medtronic Plc.
3. AngioDynamics
4. Vygon Ltd.
5. Comed B.V.
6. C.R. Bard
7. Teleflex Incorporated
8. Kimal
9. Cook Medical
10. B. Braun Melsungen AG
11. Others

Key Target Audience

1. Market Players
2. Investors
3. End-users
4. Government Authorities 
5. Consulting And Research Firm
6. Venture capitalists
7. Value-Added Resellers (VARs) 

Recent Development

• In January 2024, Scientists develop technology to prevent medical accidents related to analgesic drug infusion pump in hospitals. Excessive administration of analgesic drugs frequently results in medical accidents. To prevent the occurrence of these accidents, a drug infusion pump featuring a technology for safely detecting medication administration has been developed for the first time in the world.

• In January 2022, ICU Medical Inc. announced that it has completed its acquisition of Smiths Medical from Smiths Group plc. Combined with ICU Medical’s existing businesses, the combined companies creating a leading infusion therapy company with estimated pro forma combined revenues of approximately 2.5 billion.

•  March 2021, Smiths Medical, a leading medical device manufacturer, announced the release of the ECRI evaluation report for CADD-Solis v4 with wireless communication Patient-Controlled Analgesic (PCA) and epidural infusion pump.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Analgesics Infusion Pump Market based on the below-mentioned segments:  

Global Analgesics Infusion Pump Market, By Product Type

1. Patient-Controlled Analgesia (PCA Pump)
2. Electronic Ambulatory Pumps
3. Disposable Infusion Pumps

Global Analgesics Infusion Pump Market, By Application

1. Post-Operative Pain Management
2. Cancer Pain Management
3. Labor Pain Management
4. Chronic Pain Management

Global Analgesics Infusion Pump Market, By End User

1. Home Care Settings
2. Hospitals
3. Ambulatory Surgical Centers

Global Analgesics Infusion Pump Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific

• South America
  • Brazil
  • Argentina
  • Rest of South America

• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa